Oral administration of desloratadine prior to sensitization prevents allergen-induced airway inflammation and hyper-reactivity in mice

Clinical and Experimental Allergy

Volumn 34, Issue 7, 2004, Pages 1124-1130

  Blumchen K ^a   Gerhold, K ^a   Thorade, I ^a   Seib, C ^a   Wahn, U ^a   Hamelmann, E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Airway inflammation; Airway reactivity; Desloratadine; H1 receptor antagonist; Mice; Th1 Th2 cytokines

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; DESLORATADINE; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; METHACHOLINE; OVALBUMIN;

ALLERGIC DISEASE; ANIMAL EXPERIMENT; BRONCHUS HYPERREACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; FEMALE; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; LUNG LAVAGE; LUNG PARENCHYMA; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SPLEEN; TH2 CELL;

ADMINISTRATION, ORAL; ALLERGENS; ANIMALS; BRONCHIAL HYPERREACTIVITY; CELLS, CULTURED; FEMALE; HISTAMINE H1 ANTAGONISTS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-4; INTERLEUKIN-5; LORATADINE; LUNG; LYMPH NODES; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; OVALBUMIN; SPLEEN;

EID: 3242776074     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.01974.x     Document Type: Conference Paper

References (35)

1. Hill SJ. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol Rev 1990; 42:45-83.
2. Galli SJ. New concepts about the mast cell. N Engl J Med 1993; 328:257-65.
3. White MV, Slater JE, Kaliner MA. Histamine and asthma. Am Rev Respir Dis 1987; 135:1165-76.
4. Caron G, Delneste Y, Roelandts E et al. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J Immunol 2001; 167:3682-6.
5. Caron G, Delneste Y, Roelandts E et al. Histamine induces CD86 expression and chemokine production by human immature dendritic cells. J Immunol 2001; 166:6000-6.
6. Jutel M, Klunker S, Akdis M et al. Histamine upregulates Th1 and downregulates Th2 responses due to different patterns of surface histamine 1 and 2 receptor expression. Int Arch Allergy Immunol 2001; 124:190-2.
7. Elenkov IJ, Webster E, Papanicolaou DA, Fleisher TA, Chrousos GP, Wilder RL. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol 1998; 161:2586-93.
8. Mazzoni A, Young HA, Spitzer JH, Visintin A, Segal DM. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest 2001; 108:1865-73.
9. Lagier B, Lebel B, Bousquet J, Pene J. Different modulation by histamine of IL-4 and interferon-gamma (IFN-γ) release according to the phenotype of human Th0, Th1 and Th2 clones. Clin Exp Immunol 1997; 108:545-51.
10. Sirois J, Menard G, Moses AS, Bissonnette EY. Importance of histamine in the cytokine network in the lung through H2 and H3 receptors: stimulation of IL-10 production. J Immunol 2000; 164:2964-70.
11. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early treatment of the atopic child. Pediatr Allergy Immunol 1998; 9:116-24.
12. Bustos GJ, Bustos D, Romero O. Prevention of asthma with ketotifen in preasthmatic children: a three-year follow-up study. Clin Exp Allergy 1995; 25:568-73.
13. Iikura Y, Naspitz CK, Mikawa H et al. Prevention of asthma by ketotifen in infants with atopic dermatitis. Ann Allergy 1992; 68:233-6.
14. Hamelmann E, Schwarze J, Takeda K et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997; 156 (Part 1):766-75.
15. Hamelmann E, Vella AT, Oshiba A, Kappler JW, Marrack P, Gelfand EW. Allergic airway sensitization induces T cell activation but not airway hyperresponsiveness in B cell-deficient mice. Proc Natl Acad Sci USA 1997; 94:1350-5.
16. Gerhold K, Blumchen K, Bock A et al. Endotoxins prevent murine IgE production, TH2 immune responses, and development of airway eosinophilia but not airway hyperreactivity. J Allergy Clin Immunol 2002; 110:110-6.
17. Gelfand EW, Cui ZH, Takeda K, Kanehiro A, Joetham A. Fexofenadine modulates T-cell function, preventing allergen-induced airway inflammation and hyperresponsiveness. J Allergy Clin Immunol 2002; 110:85-95.
18. Jin HR, Okamoto Y, Matsuzaki Z, Endo S, Ito E. Cetirizine decreases interleukin-4, interleukin-5, and interferon-gamma gene expressions in nasal-associated lymphoid tissue of sensitized mice. Am J Rhinol 2002; 16:43-8.
19. Bachert C. Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis. Allergy 2001; 56 (Suppl. 65):14-20.
20. Anthes JRC, West RE. Functional characterization of desloratadine and other antihistamines in human histamine H1 receptors. In: Presented at XIXth Congress of European Academy of Allergology and Clinical Immunology; 2000; 2000.
21. Vignola AM, Crampette L, Mondain M et al. Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells. Allergy 1995; 50:200-3.
22. Lippert UK-KS, Moller A, Kiessling U, Czarnetzki BM. Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy- loratadine and dexamethasone by human mast and basophilic cell lines. Exp Dermatol 1995; 4 (Part 2):272-6.
23. Bayram H, Devalia JL, Khair OA et al. Effect of loratadine on nitrogen dioxide-induced changes in electrical resistance and release of inflammatory mediators from cultured human bronchial epithelial cells. J Allergy Clin Immunol 1999; 104:93-9.
24. Blumchen K, Kallinich T, Hamelmann E. Interleukin-5: a novel target for asthma therapy. Expert Opin Biol Ther 2001; 1:433-53.
25. Hamelmann E, Gelfand EW. Role of IL-5 in the development of allergen-induced airway hyperresponsiveness. Int Arch Allergy Immunol 1999; 120:8-16.
26. Radvany Z, Darvas Z, Kerekes K et al. H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells. Semin Cancer Biol 2000; 10:41-5.
27. Banu Y, Watanabe T. Augmentation of antigen receptor-mediated responses by histamine H1 receptor signaling. J Exp Med 1999; 189:673-82.
28. Takeda K, Haczku A, Lee JJ, Irvin CG, Gelfand EW. Strain dependence of airway hyperresponsiveness reflects differences in eosinophil localization in the lung. Am J Physiol Lung Cell Mol Physiol 2001; 281:L394-402.
29. Takeda K, Hamelmann E, Joetham A et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med 1997; 186:449-54.
30. Kobayashi T, Miura T, Haba T et al. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J Immunol 2000; 164:3855-61.
31. Mehlhop PD, van de Rijn M, Goldberg AB et al. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci USA 1997; 94:1344-9.
32. Hamelmann E, Takeda K, Schwarze J, Vella AT, Irvin CG, Gelfand EW. Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytes (see comments). Am J Respir Cell Mol Biol 1999; 21:480-9.
33. Oshiba A, Hamelmann E, Takeda K et al. Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice. J Clin Invest 1996; 97:1398-408.
34. Williams CM, Galli SJ. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 2000; 192:455-62.
35. Hamelmann E, Takeda K, Haczku A et al. Interleukin (IL)-5 but not immunoglobulin E reconstitutes airway inflammation and airway hyperresponsiveness in IL-4-deficient mice. Am J Respir Cell Mol Biol 2000; 23:327-34.